Absence of Adverse Effects in Cynomolgus Macaques Treated With CNTO 95, a Fully Human Anti- V Integrin Monoclonal Antibody, Despite Widespread Tissue Binding
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-2623
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2005
Authors
Publisher
American Association for Cancer Research (AACR)